Skip to main content

Advertisement

Contact Satoshi Tamada

From: A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer

Contact corresponding author